Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 12:12 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
View Ticker Page (MNKD)
Results 21 - 30 of 69 : 12345Next »
Recs
propet12 (< 20) Submitted: 4/10/08 8:19 AM : Start Price: $2.49 MNKD Score: 62.52
Just do your own research, think for yourself, ignore the mo-mo crowd who are only right on the days when the street decides to take their picks up. People who do the work and take the risks win in the end - just like succeeding in any business.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
fpallone (< 20) Submitted: 4/14/08 9:49 AM : Start Price: $2.41 MNKD Score: 65.67
While this took a hit from the drug announcement, the long term growth should be solid.
andy1879 (55.93) Submitted: 4/10/08 6:42 PM : Start Price: $2.58 MNKD Score: 57.32
okay i really believe market is overreacting. There's no better chance to enter right now, i got my real money on this one and i am thinking about double in short term.
snivle77 (67.54) Submitted: 4/11/08 9:25 AM : Start Price: $2.58 MNKD Score: -57.32
Their one and only product is taking a dive
ninjin274 (< 20) Submitted: 5/19/08 2:39 AM : Start Price: $3.08 MNKD Score: 39.70
Instiuitions are accumulation this stock. Should double in few days with a +ve news
edhodges (< 20) Submitted: 5/23/08 12:06 AM : Start Price: $2.97 MNKD Score: 41.87
Who wants a needle poke if there's an alternative. Mann will make it if no long term studies imposed.
PTOWNHERO (< 20) Submitted: 9/22/08 11:44 PM : Start Price: $4.05 MNKD Score: -0.86
Mannkind's recent developments have given us fools a glimpse of their potential. The Danbury production factory, phase three results (first of three), and Pfizer agreement all show promise. Alfred Mann has over f...
biopharminvestor (47.22) Submitted: 9/16/08 9:28 PM : Start Price: $2.88 MNKD Score: 33.36
Great technology, drug delivery + therapeutics; Could dominate the diabetes-insulin space. Marketing application EOY; Oversold on Exubera and inhaled insulin worries; Released positive pivotal results 16-Sept that Market misunderstood. Market Ca...
cmbourne (< 20) Submitted: 9/15/08 12:39 PM : Start Price: $3.55 MNKD Score: -12.72
inhaling large protein molecules into the lung is a bad idea.Doctors won't prescribe it. It will be a repeat of Exubra.look at GNBT
Kryptos13 (27.25) Submitted: 8/18/08 12:49 AM : Start Price: $3.51 MNKD Score: 18.84
Close to a low, and its a cheap stock, meaning a boom can result soon, even during recession.
Terms & Conditions
RSS Headlines
Fool UK